These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25141332)

  • 1. Do we have to worry for thrombocytopenia during treatment of hepatitis C.
    Ince AT
    Turk J Gastroenterol; 2014 Jun; 25(3):344-5. PubMed ID: 25141332
    [No Abstract]   [Full Text] [Related]  

  • 2. Is treatment of moderate thrombocytopenia indicated for patients with HCV infection and cirrhosis?
    Desborough MJ; Jairath V
    Gastroenterology; 2014 Jul; 147(1):254. PubMed ID: 24877869
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply: To PMID 24126097.
    Afdhal NH; Theodore D
    Gastroenterology; 2014 Jul; 147(1):255-6. PubMed ID: 24877870
    [No Abstract]   [Full Text] [Related]  

  • 4. Does eltrombopag really ENABLE SVR?
    Leber A; Feld JJ
    Gastroenterology; 2014 Feb; 146(2):339-42. PubMed ID: 24361434
    [No Abstract]   [Full Text] [Related]  

  • 5. Eltrombopag for thrombocytopenic patients with hepatitis C virus infection and cirrhosis.
    Ji F; Deng H; Li Z
    Gastroenterology; 2014 Jul; 147(1):253-4. PubMed ID: 24877867
    [No Abstract]   [Full Text] [Related]  

  • 6. Eltrombopag for thrombocytopenic patients with chronic HCV infection.
    Maan R; Veldt BJ; Janssen HL
    Gastroenterology; 2014 Jul; 147(1):254-5. PubMed ID: 24877871
    [No Abstract]   [Full Text] [Related]  

  • 7. Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy.
    Afdhal NH; Dusheiko GM; Giannini EG; Chen PJ; Han KH; Mohsin A; Rodriguez-Torres M; Rugina S; Bakulin I; Lawitz E; Shiffman ML; Tayyab GU; Poordad F; Kamel YM; Brainsky A; Geib J; Vasey SY; Patwardhan R; Campbell FM; Theodore D
    Gastroenterology; 2014 Feb; 146(2):442-52.e1. PubMed ID: 24126097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eltrombopag in chronic hepatitis C.
    Mihăilă RG; Cipăian RC
    World J Gastroenterol; 2014 Sep; 20(35):12517-21. PubMed ID: 25253952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecule of the month. Eltrombopag.
    Drug News Perspect; 2008; 21(6):344. PubMed ID: 18836592
    [No Abstract]   [Full Text] [Related]  

  • 10. [Eltrombopag for the treatment of thrombocytopenia in patients with chronic hepatitis C: two case reports].
    Guglieri-López B; Ventura-Cerdá JM; Carmena-Carmena J; Climente-Mónica M
    Farm Hosp; 2013; 37(5):419-21. PubMed ID: 24128106
    [No Abstract]   [Full Text] [Related]  

  • 11. Economic assessment of eltrombopag in the treatment of thrombocytopenia.
    Romano F; Ruggeri M; Coretti S; Giannini EG; Sacchini D; Annichiarico BE; Marchetti M; Rodeghiero F; Lidonnici D
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(4):713-20. PubMed ID: 26176754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune thrombocytopenic purpura--from agony to agonist.
    Schwartz RS
    N Engl J Med; 2007 Nov; 357(22):2299-301. PubMed ID: 18046034
    [No Abstract]   [Full Text] [Related]  

  • 13. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.
    McHutchison JG; Dusheiko G; Shiffman ML; Rodriguez-Torres M; Sigal S; Bourliere M; Berg T; Gordon SC; Campbell FM; Theodore D; Blackman N; Jenkins J; Afdhal NH;
    N Engl J Med; 2007 Nov; 357(22):2227-36. PubMed ID: 18046027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in thrombocytopenic patients with chronic hepatitis C with or without cirrhosis in the ENABLE-1 and ENABLE-2 studies.
    Grotzinger KM; Younossi ZM; Giannini EG; Chen PJ; Rendas-Baum R; Theodore D
    Health Qual Life Outcomes; 2016 Mar; 14():49. PubMed ID: 27004952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eltrombopag in thrombocytopenia.
    Lawson A
    N Engl J Med; 2008 Mar; 358(10):1072; author reply 1072-3. PubMed ID: 18322290
    [No Abstract]   [Full Text] [Related]  

  • 16. Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children.
    Ali S; Gassas A; Kirby-Allen M; Krueger J; Ali M; Schechter T
    Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28653480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eltrombopag in patients with chronic liver disease.
    Giannini EG; Afdhal NH
    Expert Opin Pharmacother; 2013 Apr; 14(5):669-78. PubMed ID: 23452139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.
    Violi F; Pignatelli P
    N Engl J Med; 2012 Nov; 367(21):2056. PubMed ID: 23171115
    [No Abstract]   [Full Text] [Related]  

  • 19. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.
    Lisman T; Porte RJ
    N Engl J Med; 2012 Nov; 367(21):2055-6. PubMed ID: 23171114
    [No Abstract]   [Full Text] [Related]  

  • 20. Nontransfusional approach to increased platelet count in patients with cirrhosis and thrombocytopenia.
    Tripodi A; Primignani M
    Hepatology; 2013 Sep; 58(3):1177-80. PubMed ID: 23703879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.